Abstract:Rapid diagnostic tests are crucial for timely disease detection and management, yet accurate interpretation of test results remains challenging. In this study, we propose a novel approach to enhance the accuracy and reliability of rapid diagnostic test result interpretation by integrating artificial intelligence (AI) algorithms, including convolutional neural networks (CNN), within a smartphone-based application. The app enables users to take pictures of their test kits, which YOLOv8 then processes to precisely crop and extract the membrane region, even if the test kit is not centered in the frame or is positioned at the very edge of the image. This capability offers greater accessibility, allowing even visually impaired individuals to capture test images without needing perfect alignment, thus promoting user independence and inclusivity. The extracted image is analyzed by an additional CNN classifier that determines if the results are positive, negative, or invalid, providing users with the results and a confidence level. Through validation experiments with commonly used rapid test kits across various diagnostic applications, our results demonstrate that the synergistic integration of AI significantly improves sensitivity and specificity in test result interpretation. This improvement can be attributed to the extraction of the membrane zones from the test kit images using the state-of-the-art YOLO algorithm. Additionally, we performed SHapley Additive exPlanations (SHAP) analysis to investigate the factors influencing the model's decisions, identifying reasons behind both correct and incorrect classifications. By facilitating the differentiation of genuine test lines from background noise and providing valuable insights into test line intensity and uniformity, our approach offers a robust solution to challenges in rapid test interpretation.

Performance of an artificial intelligence-based smartphone app for guided reading of SARS-CoV-2 lateral-flow immunoassays

A Smartphone-Based Platform Assisted by Artificial Intelligence for Reading and Reporting Rapid Diagnostic Tests: Evaluation Study in SARS-CoV-2 Lateral Flow Immunoassays

Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation

Proof-of-Concept: Smartphone- and Cloud-Based Artificial Intelligence Quantitative Analysis System (SCAISY) for SARS-CoV-2-Specific IgG Antibody Lateral Flow Assays

Evaluation of a smartphone‐operated point‐of‐care device using loop‐mediated isothermal amplification technology for rapid and remote detection of SARS‐CoV‐2

Feasibility of using intermittent active monitoring of vital signs by smartphone users to predict SARS-CoV-2 PCR positivity

Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies

AI-Driven Smartphone Solution for Digitizing Rapid Diagnostic Test Kits and Enhancing Accessibility for the Visually Impaired

Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR

Artificial Intelligence-Based Portable Bioelectronics Platform for SARS-CoV-2 Diagnosis with Multi-nucleotide Probe Assay for Clinical Decisions

Artificial intelligence-driven mobile interpretation of a semi-quantitative cryptococcal antigen lateral flow assay

Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-Care

Detection of SARS-CoV-2 Based on Artificial Intelligence-Assisted Smartphone: A Review

Detection of COVID-19: A Smartphone-Based Machine-Learning-Assisted ECL Immunoassay Approach with the Ability of RT-PCR CT Value Prediction

System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports

Artificial intelligence-assisted colorimetric lateral flow immunoassay for sensitive and quantitative detection of COVID-19 neutralizing antibody

Usability and performance of the MicroGEM Sal6830, an RT-PCR saliva-based point-of-care platform to detect SARS-CoV-2 in primary healthcare settings with non-laboratory trained operators.

Predictive model for real-world performance of COVID-19 antigen tests based on laboratory evaluation

Automated Low-Cost Smartphone-Based Lateral Flow Saliva Test Reader for Drugs-of-Abuse Detection

SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination

Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values